New toolkit aims to improve End-of-Life care talks for dementia patients

NCT ID NCT06565169

Recruiting now Knowledge-focused Sponsor: University of Pittsburgh Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a special training toolkit helps doctors and nurses have better conversations about future medical care with people living with Alzheimer's or related dementias. The researchers will compare clinics that use the toolkit to those that continue usual care, tracking how often and how well these important discussions happen. The goal is to improve advance care planning, including choosing a surrogate decision-maker and documenting care preferences.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dementia Advance Care Planning (AD ACP) Toolkit training
What this could lead to: If successful, this could give doctors a practical way to have better conversations about future care with dementia patients, leading to more personalized and planned care.
What could go wrong: This is a small, early-stage study focused on training doctors, not directly treating dementia. The toolkit may not work in all clinics or improve actual patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Communication dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGING ALZHEIMER DISEASE ALZHEIMER'S DISEASE (INCL SUBTYPES) DEMENTIA

Contacts and locations

Locations

University of North Carolina, Chapel Hill
RECRUITING

Chapel Hill, North Carolina, 27599, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.